Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy

European Urology

Volumn 61, Issue 3, 2012, Pages 443-451

  Stephenson, Andrew J ^a   Bolla, Michel ^b   Briganti, Alberto ^c   Cozzarini, Cesare ^d   Moul, Judd W ^e   Roach Iii, MacK ^f   Van Poppel, Hein ^g   Zietman, Anthony ^h  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIV GRENOBLE ALPES   (France)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e DUKE UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Neoplasm recurrence, local; Prostate specific antigen; Prostatectomy; Prostatic neoplasms; Radiotherapy; Radiotherapy, adjuvant; Salvage therapy; Treatment outcome

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; HIGH RISK PATIENT; HUMAN; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME;

EID: 84856365558     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.10.010     Document Type: Review

References (59)

1. J.W. Moul Prostate specific antigen only progression of prostate cancer J Urol 163 2000 1632 1642 (Pubitemid 30366704)
2. A.J. Stephenson, P.T. Scardino, and J.A. Eastham Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Natl Cancer Inst 98 2006 715 717 (Pubitemid 43821789)
3. P.A. Kupelian, M. Elshaikh, C.A. Reddy, C. Zippe, and E.A. Klein Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy J Clin Oncol 20 2002 3376 3385
4. C.R. Pound, A.W. Partin, J.I. Epstein, and P.C. Walsh Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control Urol Clin North Am 24 1997 395 406 (Pubitemid 27169264)
5. A. Patel, F. Dorey, J. Franklin, and J.B. deKernion Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen J Urol 158 1997 1441 1445 (Pubitemid 27391215)
6. S.G. Roberts, M.L. Blute, E.J. Bergstralh, J.M. Slezak, and H. Zincke PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer Mayo Clin Proc 76 2001 576 581
7. G.P. Swanson, M.A. Hussey, and C.M. Tangen SWOG 8794. Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794 J Clin Oncol 25 2007 2225 2229 (Pubitemid 46954647)
8. A. Bill-Axelson, L. Holmberg, and M. Ruutu SPCG-4 Investigators. Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 352 2005 1977 1984 (Pubitemid 40638368)
9. D.J. Lightner, P.H. Lange, P.K. Reddy, and L. Moore Prostate specific antigen and local recurrence after radical prostatectomy J Urol 144 1990 921 926 (Pubitemid 20324820)
10. A.K. Leventis, S.F. Shariat, and K.M. Slawin Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings Radiology 219 2001 432 439 (Pubitemid 32336357)
11. G.V. Raj, A.W. Partin, and T.J. Polascik Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy Cancer 94 2002 987 996 (Pubitemid 34150853)
12. T. Sella, L.H. Schwartz, and P.W. Swindle Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging Radiology 231 2004 379 385 (Pubitemid 38552892)
13. A.J. Stephenson, S.F. Shariat, and M.J. Zelefsky Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325 1332 (Pubitemid 38541647)
14. A.J. Stephenson, P.T. Scardino, and M.W. Kattan Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041 (Pubitemid 46972788)
15. A.J. Stephenson, and K.M. Slawin The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy Nat Clin Pract Urol 1 2004 90 96 (Pubitemid 40823734)
16. M.S. Katz, M.J. Zelefsky, E.S. Venkatraman, Z. Fuks, A. Hummer, and S.A. Leibel Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer J Clin Oncol 21 2003 483 489 (Pubitemid 46606478)
17. I.M. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial J Urol 181 2009 956 962
18. M. Bolla, H. van Poppel, and L. Collette European Organization for Research and Treatment of Cancer. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578
19. T. Wiegel, D. Bottke, and U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
20. O.K. MacDonald, S.E. Schild, and S. Vora Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ? Urology 64 2004 760 764 (Pubitemid 39446058)
21. B.J. Trock, M. Han, and S.J. Freedland Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy JAMA 299 2008 2760 2769 (Pubitemid 351846851)
22. D.A. Berry, K.A. Cronin, and S.K. Plevritis Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer N Engl J Med 353 2005 1784 1792
23. J.E. Krook, C.G. Moertel, and L.L. Gunderson Effective surgical adjuvant therapy for high-risk rectal carcinoma N Engl J Med 324 1991 709 715
24. C.R. Pound, A.W. Partin, M.A. Eisenberger, D.W. Chan, J.D. Pearson, and P.C. Walsh Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597 (Pubitemid 29211767)
25. M.S. Anscher Salvage radiotherapy for recurrent prostate cancer: the earlier the better JAMA 291 2004 1380 1382 (Pubitemid 38541653)
26. M.S. Anscher Adjuvant radiotherapy following radical prostatectomy is more effective and less toxic than salvage radiotherapy for a rising prostate specific antigen Int J Cancer 96 2001 91 93 (Pubitemid 32291428)
27. C.R. King, and D.S. Kapp Radiotherapy after prostatectomy: is the evidence for dose escalation out there? Int J Radiat Oncol Biol Phys 71 2008 346 350
28. C. Cozzarini, F. Montorsi, and C. Fiorino Need for high radiation dose (>or = 70 Gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients Int J Radiat Oncol Biol Phys 75 2009 966 974
29. E.J. Trabulsi, R.K. Valicenti, and A.L. Hanlon A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer Urology 72 2008 1298 1302 discussion 1302-4
30. C.T. Thomas, P.T. Bradshaw, and B.H. Pollock Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy J Clin Oncol 21 2003 1715 1721 (Pubitemid 46638582)
31. R.K. Valicenti, L.G. Gomella, and M. Ismail The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis Int J Radiat Oncol Biol Phys 45 1999 53 58 (Pubitemid 29380074)
32. J.J. Wu, S.C. King, G.S. Montana, C.A. McKinstry, and M.S. Anscher The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen Int J Radiat Oncol Biol Phys 32 1995 317 323
33. C. Catton, M. Gospodarowicz, and P. Warde Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate Radiother Oncol 59 2001 51 60 (Pubitemid 32261076)
34. P. Ost, B. De Troyer, V. Fonteyne, W. Oosterlinck, and G. De Meerleer A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 80 2011 1316 1322
35. T. Budiharto, C. Perneel, and K. Haustermans A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy Radiother Oncol 97 2010 474 479
36. A.J. Stephenson, D.P. Wood, and M.W. Kattan Location, extent, and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy compared to their presence or absence J Urol 182 2009 1357 1363
37. F.J. Bianco Jr., P.T. Scardino, and J.A. Eastham Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta") Urology 66 2005 83 94 (Pubitemid 41356564)
38. G.W. Hull, F. Rabbani, F. Abbas, T.M. Wheeler, M.W. Kattan, and P.T. Scardino Cancer control with radical prostatectomy alone in 1,000 consecutive patients J Urol 167 2002 528 534 (Pubitemid 34074521)
39. I.M. Thompson Jr., C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial JAMA 296 2006 2329 2335 (Pubitemid 44749360)
40. P.J. Van Cangh, F. Richard, and F. Lorge Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study J Urol 159 1998 164 166 (Pubitemid 27525595)
41. T.H. Van der Kwast, M. Bolla, and H. Van Poppel EORTC 22911. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911 J Clin Oncol 25 2007 4178 4186 (Pubitemid 47548556)
42. H. Van Poppel, M. Bolla, and B. Tombal EORTC ROG and GU Groups. Adjuvant radiotherapy after radical prostatectomy in patients with pathologically high risk prostate cancer: 10-year follow-up results Eur Urol Suppl 10 2011 93 Abstract 227
43. A.L. Zietman, M.L. DeSilvio, and J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial JAMA 294 2005 1233 1239 (Pubitemid 41352111)
44. P. Ost, V. Fonteyne, G. Villeirs, N. Lumen, W. Oosterlinck, and G. De Meerleer Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients Eur Urol 56 2009 669 677
45. G. De Meerleer, V. Fonteyne, and S. Meersschout Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy Radiother Oncol 89 2008 205 213
46. J.D. Cox, M.J. Gallagher, E.H. Hammond, R.S. Kaplan, and P.F. Schellhammer Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel J Clin Oncol 17 1999 1155
47. A.J. Stephenson, P.T. Scardino, and J.A. Eastham Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Clin Oncol 23 2005 7005 7012
48. S.E. Eggener, P.T. Scardino, and P.C. Walsh Predicting 15-year prostate cancer specific mortality after radical prostatectomy J Urol 185 2011 869 875
49. D.J. Brenner, R.E. Curtis, E.J. Hall, and E. Ron Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery Cancer 88 2000 398 406 (Pubitemid 30051826)
50. K. Moon, G.J. Stukenborg, J. Keim, and D. Theodorescu Cancer incidence after localized therapy for prostate cancer Cancer 107 2006 991 998 (Pubitemid 44291148)
51. P. Poortmans, A. Bossi, and K. Vandeputte EORTC Radiation Oncology Group. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group Radiother Oncol 84 2007 121 127 (Pubitemid 47284534)
52. M.V. Pilepich, K. Winter, and M.J. John Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Int J Radiat Oncol Biol Phys 50 2001 1243 1252 (Pubitemid 32727802)
53. M. Bolla, L. Collette, and L. Blank Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial Lancet 360 2002 103 106
54. M. Bolla Duration of androgen suppression in the treatment of prostate cancer N Engl J Med 360 2009 2516 2527
55. A.V. D'Amico, J. Manola, M. Loffredo, A.A. Renshaw, A. DellaCroce, and P.W. Kantoff 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial JAMA 292 2004 821 827 (Pubitemid 39079668)
56. D.G. McLeod, P. Iversen, W.A. See, T. Morris, J. Armstrong, and M.P. Wirth Casodex Early Prostate Cancer Trialists' Group. Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer BJU Int 97 2006 247 254
57. M.P. Wirth, W.A. See, D.G. McLeod, P. Iversen, T. Morris, and K. Carroll Casodex Early Prostate Cancer Trialists' Group. Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5 4 years. J Urol 172 2004 1865 1870 (Pubitemid 39363075)
58. G.K. Zagars, A. Pollack, and A.C. von Eschenbach Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer Urology 58 2001 233 239 (Pubitemid 32728063)
59. L.F. Da Pozzo, C. Cozzarini, and A. Briganti Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy Eur Urol 55 2009 1003 1011